Insider · CIK 0001704417

Dispersyn Gerrit

Reports to the SEC for 1 company · MARLBOROUGH, MA

sec.gov

Transactions

Companies

Filings

CIK

0001704417

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-03-01	PHIOPhio Pharmaceuticals Corp.F Tax Payment	Director, President & CEO	FTax Payment	−8,954 sh	$0.82	−$7,351.234	212,327
2022-02-15	PHIOPhio Pharmaceuticals Corp.A Award	Director, President & CEO	AAward	+126K sh	—	—	221,281
2021-08-16	PHIOPhio Pharmaceuticals Corp.P Purchase	Director, President & CEO	PPurchase	+6,000 sh	$1.63	+$9,780	95,281
2021-03-04	PHIOPhio Pharmaceuticals Corp.P Purchase	Director, President & CEO	PPurchase	+1,953 sh	$2.56	+$4,999.68	89,281
2021-03-03	PHIOPhio Pharmaceuticals Corp.P Purchase	Director, President & CEO	PPurchase	+2,500 sh	$3.03	+$7,575	87,328
2021-03-01	PHIOPhio Pharmaceuticals Corp.A Award	Director, President & CEO	AAward	+68.5K sh	—	—	84,828
2020-08-19	PHIOPhio Pharmaceuticals Corp.P Purchase	Director, President & CEO	PPurchase	+2,000 sh	$2.50	+$5,000	16,377
2020-03-01	PHIOPhio Pharmaceuticals Corp.F Tax Payment	Director, President & CEO	FTax Payment	−673 sh	$2.93	−$1,971.89	14,628
2019-11-18	PHIOPhio Pharmaceuticals Corp.A Award	Director, President & CEO	AAward	+350K sh	$0.10	+$35K	827,817
2019-08-01	PHIOPhio Pharmaceuticals Corp.F Tax Payment	Director, President & CEO	FTax Payment	−1,236 sh	$0.40	−$498.108	477,817
2019-03-01	PHIOPhio Pharmaceuticals Corp.A Award	Director, President & CEO	AAward	+408K sh	—	—	479,053
2019-02-13	PHIOPhio Pharmaceuticals Corp.A Award	Director, President & CEO	AAward	+55K sh	—	—	71,350
2018-08-01	PHIOPhio Pharmaceuticals Corp. · Stock option (right to buy)A Award	Director, President & CEO	AAward	+16K sh	—	—	16,000
2018-08-01	PHIOPhio Pharmaceuticals Corp.A Award	Director, President & CEO	AAward	+16K sh	—	—	16,350
2017-06-23	PHIOPhio Pharmaceuticals Corp.P Purchase	Director, President & CEO	PPurchase	+3,500 sh	$0.62	+$2,170	3,500
2017-04-24	PHIOPhio Pharmaceuticals Corp. · Stock option (right to buy)A Award	Director, President & CEO	AAward	+95K sh	—	—	95,000

Recent filings

Accepted (ET)
Mar 34
Dispersyn Gerrit0001209191-22-015893
SEC(opens sec.gov)
Feb 164
Dispersyn Gerrit0001209191-22-010384
SEC(opens sec.gov)
Aug 174
Dispersyn Gerrit0001209191-21-051759
SEC(opens sec.gov)
Mar 54
Dispersyn Gerrit0001209191-21-018054
SEC(opens sec.gov)
Mar 34
Dispersyn Gerrit0001209191-21-017569
SEC(opens sec.gov)
Aug 194
Dispersyn Gerrit0001209191-20-047533
SEC(opens sec.gov)
Mar 34
Dispersyn Gerrit0001209191-20-015801
SEC(opens sec.gov)
Nov 204
Dispersyn Gerrit0001209191-19-057511
SEC(opens sec.gov)
Aug 24
Dispersyn Gerrit0001209191-19-044367
SEC(opens sec.gov)
Mar 54
Dispersyn Gerrit0001209191-19-017201
SEC(opens sec.gov)
Feb 154
Dispersyn Gerrit0001209191-19-010820
SEC(opens sec.gov)
Aug 34
Dispersyn Gerrit0001209191-18-045455
SEC(opens sec.gov)
Jun 264
RXi Pharmaceuticals Corp0001209191-17-041790
SEC(opens sec.gov)
Apr 264
RXi Pharmaceuticals Corp0001209191-17-028260
SEC(opens sec.gov)

Companies

Phio Pharmaceuticals Corp.Director, President & CEOPHIO

Address

C/O 257 SIMARANO DRIVE, SUITE 101

MARLBOROUGH, MA, 01752